Medicine versus catheter procedure for serious lung clots
Part of Lungs & breathing clinical trials.
This study compares two treatments for a serious type of blood clot in the lungs called acute intermediate-high risk pulmonary embolism. It tests whether clot-busting medicine is better than a catheter procedure to clear the clot and help you recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pulmonary embolism that is rated as 'intermediate-high' risk.
- You are 18 years of age or older.
- You do not have a mass or clot in the right ventricle of your heart.
- You are willing to accept either medicine or a catheter-based treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to remove blood clots from the lungs in people with a serious pulmonary embolism. It may help improve blood flow and reduce strain on the heart.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.